Publication: Psoriasis and risk of incident atrial fibrillation: A systematic review and meta-analysis
dc.contributor.author | Patompong Ungprasert | en_US |
dc.contributor.author | Narat Srivali | en_US |
dc.contributor.author | Wonngarm Kittanamongkolchai | en_US |
dc.contributor.other | Mayo Clinic | en_US |
dc.contributor.other | Mahidol University | en_US |
dc.date.accessioned | 2018-12-11T03:27:32Z | |
dc.date.accessioned | 2019-03-14T08:02:08Z | |
dc.date.available | 2018-12-11T03:27:32Z | |
dc.date.available | 2019-03-14T08:02:08Z | |
dc.date.issued | 2016-09-01 | en_US |
dc.description.abstract | © 2016 Indian Journal of Dermatology, Venereology, and Leprology Published by Wolters Kluwer - Medknow. Background and Objectives: Patients with psoriasis might have a higher risk of developing atrial fibrillation as a result of chronic inflammation. This study aimed to investigate this association by comprehensively reviewing all available evidence. Methods: We conducted a systematic review and meta-analysis of cohort studies that reported relative risk, hazard ratio, incidence ratio or standardized incidence ratio with 95% confidence intervals comparing the risk of incident atrial fibrillation in patients with psoriasis versus participants without psoriasis. Both retrospective and prospective cohort studies were eligible. Pooled risk ratio and 95% confidence intervals were calculated using random-effect, generic inverse variance methods of DerSimonian and Laird. Results: Three retrospective studies with 110,568 cases of psoriasis and 5,352,817 participants without psoriasis were included in this meta-analysis. The pooled risk ratio of subsequent development of atrial fibrillation in patients with psoriasis versus participants without psoriasis was 1.21 (95% confidence interval, 1.14-1.29). The statistical heterogeneity was low with an I2of 29%. Limitations: Coding-based design of the primary studies that had limited accuracy. Conclusions: Our meta-analysis demonstrated a statistically significant increase in the risk of incident atrial fibrillation among patients with psoriasis. | en_US |
dc.identifier.citation | Indian Journal of Dermatology, Venereology and Leprology. Vol.82, No.5 (2016), 489-497 | en_US |
dc.identifier.doi | 10.4103/0378-6323.186480 | en_US |
dc.identifier.issn | 09733922 | en_US |
dc.identifier.issn | 03786323 | en_US |
dc.identifier.other | 2-s2.0-84983661488 | en_US |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/41194 | |
dc.rights | Mahidol University | en_US |
dc.rights.holder | SCOPUS | en_US |
dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84983661488&origin=inward | en_US |
dc.subject | Medicine | en_US |
dc.title | Psoriasis and risk of incident atrial fibrillation: A systematic review and meta-analysis | en_US |
dc.type | Review | en_US |
dspace.entity.type | Publication | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84983661488&origin=inward | en_US |